Nature 432, 938, 10.1038/432938a (2004)
Some individuals may experience temporary appetite increases or mild blood sugar dips
Stop and Seek Help If Any signs of allergic reactionhives, swelling, breathing difficulty (stop immediately, seek help) Severe or persistent headaches that don't respond to dose reduction Excessive daytime drowsiness affecting your ability to function Unusual mood changes or psychological symptoms You've completed your planned cycle (typically 4-6 weeks) Your healthcare provider recommends discontinuation DSIP is a research peptide, not an FDA-approved medication
Over 50 and on semaglutide Age-related muscle loss, sarcopenia, compounds the muscle loss risk from semaglutide
Given the multiple pathophysiologic targets that exist in the setting of T2DM, it is common to encounter patients who require the use of multiple antihyperglycemic agents to successfully reach treatment goals